290 related articles for article (PubMed ID: 21677375)
1. Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease.
Blazquez-Llorca L; Garcia-Marin V; Merino-Serrais P; Ávila J; DeFelipe J
J Alzheimers Dis; 2011; 26(4):683-98. PubMed ID: 21677375
[TBL] [Abstract][Full Text] [Related]
2. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
[TBL] [Abstract][Full Text] [Related]
3. A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients.
Furcila D; DeFelipe J; Alonso-Nanclares L
J Alzheimers Dis; 2018; 64(2):417-435. PubMed ID: 29914033
[TBL] [Abstract][Full Text] [Related]
4. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
5. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer's disease: cellular and molecular aspects].
Octave JN; Pierrot N
Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
[TBL] [Abstract][Full Text] [Related]
7. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
Pamphlett R; Kum Jew S
J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
[TBL] [Abstract][Full Text] [Related]
8. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation.
Su JH; Deng G; Cotman CW
Neurobiol Dis; 1997; 4(5):365-75. PubMed ID: 9440125
[TBL] [Abstract][Full Text] [Related]
9. Neurodegeneration and plasticity.
Arendt T
Int J Dev Neurosci; 2004 Nov; 22(7):507-14. PubMed ID: 15465280
[TBL] [Abstract][Full Text] [Related]
10. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
11. The pathological process underlying Alzheimer's disease in individuals under thirty.
Braak H; Del Tredici K
Acta Neuropathol; 2011 Feb; 121(2):171-81. PubMed ID: 21170538
[TBL] [Abstract][Full Text] [Related]
12. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol and tau protein--findings in Alzheimer's and Niemann Pick C's disease.
Ohm TG; Treiber-Held S; Distl R; Glöckner F; Schönheit B; Tamanai M; Meske V
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S120-6. PubMed ID: 14574625
[TBL] [Abstract][Full Text] [Related]
14. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
15. From the Entorhinal Region via the Prosubiculum to the Dentate Fascia: Alzheimer Disease-Related Neurofibrillary Changes in the Temporal Allocortex.
Braak H; Del Tredici K
J Neuropathol Exp Neurol; 2020 Feb; 79(2):163-175. PubMed ID: 31913466
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
17. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
18. Casein kinase II alteration precedes tau accumulation in tangle formation.
Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
20. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
